Irish medtech firm Neuromod Devices sets up US subsidiary

The company, which specialises in treatment of tinnitus, announces three US-based executive appointments as it seeks FDA approval for its product

Ross O’Neill, chief executive of Neuromod Devices, said the company aims to meet the needs of the estimated 50 million people in the US with tinnitus. Picture: Fergal Phillips

Neuromod Devices, the Irish medical device company specialising in the treatment of tinnitus, has announced the establishment of Neuromod USA Inc, a subsidiary headquartered in Oak Brook, Illinois.

The company also announced the appointment of three executives to Neuromod USA’s leadership team as the newly formed business prepares to enter the US market with its medical device for tinnitus treatment, pending approval from the Food and Drug Administration.

Stephanie Glowacki has been appointed chief financial ...